Clinical Efficacy and Safety of EGFR-TKI Combined With Nimotuzumab in the Treatment of Leptomeningeal Metastases From Lung Cancer
Conditions:   Leptomeningeal Metastasis;   Lung Cancer Intervention:   Drug: Nimotuzumab Sponsor:   Hui Bu Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 6, 2021 Category: Research Source Type: clinical trials